Larvol Delta - Regulus-Therapeutics-Announces-Completion-of-Enrollment-in-First-Cohort-of-Phase-1b-Clinical-Trial-of-RGLS4326-for-the-Treatment-of-Patients-with-Autosomal-Dominant-Polycystic-Kidney-Disease-ADPKD

RGLS4326 - Regulus Therapeutics, Bio-Techne

https://www.prnewswire.com/news-releases/regulus-therapeutics-announces-completion-of-enrollment-in-first-cohort-of-phase-1b-clinical-trial-of-rgls4326-for-the-treatment-of-patients-with-autosomal-dominant-polycystic-kidney-disease-adpkd-301225753.html

Feb 11, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next